These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

453 related articles for article (PubMed ID: 15203099)

  • 1. Polycystic kidney disease: new understanding in the pathogenesis.
    Wilson PD
    Int J Biochem Cell Biol; 2004 Oct; 36(10):1868-73. PubMed ID: 15203099
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autosomal dominant polycystic kidney disease (ADPKD, MIM 173900, PKD1 and PKD2 genes, protein products known as polycystin-1 and polycystin-2).
    Boucher C; Sandford R
    Eur J Hum Genet; 2004 May; 12(5):347-54. PubMed ID: 14872199
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular genetics of polycystic kidney disease.
    Calvet JP
    J Nephrol; 1998; 11(1):24-34. PubMed ID: 9561482
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The pathogenesis of polycystic kidney disease.
    Carone FA; Bacallao R; Kanwar YS
    Histol Histopathol; 1995 Jan; 10(1):213-21. PubMed ID: 7756739
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polycystic kidney disease and the renal cilium.
    Deane JA; Ricardo SD
    Nephrology (Carlton); 2007 Dec; 12(6):559-64. PubMed ID: 17995581
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cellular pathophysiology of cystic kidney disease: insight into future therapies.
    Avner ED; Woychik RP; Dell KM; Sweeney WE
    Int J Dev Biol; 1999; 43(5):457-61. PubMed ID: 10535324
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Pathogenesis of cystic kidney diseases].
    Walz G
    Verh Dtsch Ges Pathol; 2002; 86():138-44. PubMed ID: 12647363
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Polycystic kidney diseases: molecular genetics and counselling].
    Lespinasse J; Fourcade J; Schir F
    Nephrol Ther; 2006 Jul; 2(3):120-6. PubMed ID: 16890136
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polycystic liver and kidney diseases.
    Tahvanainen E; Tahvanainen P; Kääriäinen H; Höckerstedt K
    Ann Med; 2005; 37(8):546-55. PubMed ID: 16338757
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Recent advances in molecular pathogenesis and treatment of polycystic kidney disease].
    Covic M; Covic M
    Rev Med Chir Soc Med Nat Iasi; 2008; 112(1):11-20. PubMed ID: 18677899
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pax2 gene dosage influences cystogenesis in autosomal dominant polycystic kidney disease.
    Stayner C; Iglesias DM; Goodyer PR; Ellis L; Germino G; Zhou J; Eccles MR
    Hum Mol Genet; 2006 Dec; 15(24):3520-8. PubMed ID: 17082250
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Apico-basal polarity in polycystic kidney disease epithelia.
    Wilson PD
    Biochim Biophys Acta; 2011 Oct; 1812(10):1239-48. PubMed ID: 21658447
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autosomal dominant polycystic kidney disease: molecular genetics and pathophysiology.
    Sutters M; Germino GG
    J Lab Clin Med; 2003 Feb; 141(2):91-101. PubMed ID: 12577044
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular and cellular pathophysiology of autosomal recessive polycystic kidney disease (ARPKD).
    Sweeney WE; Avner ED
    Cell Tissue Res; 2006 Dec; 326(3):671-85. PubMed ID: 16767405
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lowering of Pkd1 expression is sufficient to cause polycystic kidney disease.
    Lantinga-van Leeuwen IS; Dauwerse JG; Baelde HJ; Leonhard WN; van de Wal A; Ward CJ; Verbeek S; Deruiter MC; Breuning MH; de Heer E; Peters DJ
    Hum Mol Genet; 2004 Dec; 13(24):3069-77. PubMed ID: 15496422
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TRP channels and kidney disease: lessons from polycystic kidney disease.
    Qamar S; Vadivelu M; Sandford R
    Biochem Soc Trans; 2007 Feb; 35(Pt 1):124-8. PubMed ID: 17233617
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cell polarity in human renal cystic disease.
    Carone FA; Nakamura S; Caputo M; Bacallao R; Nelson WJ; Kanwar YS
    Lab Invest; 1994 May; 70(5):648-55. PubMed ID: 8196361
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Heterozygosity loss and somatic mutations in type I and II dominant autosomal renal polycystic kidney disease: evidence of a recessive mechanism at a cell level in cystogenesis].
    Pérez-Oller L; Torra R; Badenas C; San Millán JL; Darnell A
    Nefrologia; 2000; 20(2):130-8. PubMed ID: 10853193
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiovascular, skeletal, and renal defects in mice with a targeted disruption of the Pkd1 gene.
    Boulter C; Mulroy S; Webb S; Fleming S; Brindle K; Sandford R
    Proc Natl Acad Sci U S A; 2001 Oct; 98(21):12174-9. PubMed ID: 11593033
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutations of the human polycystic kidney disease 2 (PKD2) gene.
    Deltas CC
    Hum Mutat; 2001; 18(1):13-24. PubMed ID: 11438989
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.